Skip to Content
Merck
All Photos(1)

Key Documents

880170P

Avanti

C8 PEG2000 Ceramide

Avanti Research - A Croda Brand 880170P, powder

Synonym(s):

N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)2000]}

Sign Into View Organizational & Contract Pricing


About This Item

CAS Number:
UNSPSC Code:
12352211
NACRES:
NA.25

form

powder

packaging

pkg of 1 × 25 mg (880170P-25mg)

manufacturer/tradename

Avanti Research - A Croda Brand 880170P

shipped in

dry ice

storage temp.

−20°C

SMILES string

[H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCC)=O)COC(CCC(OOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOC)=O)=O.C=C

General description

C8 PEG2000 Ceramide, also known as N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)2000]}, is a polyethylene glycol (PEG)-modified lipid. Ceramide-PEGylated lipoplexes deliver siRNA to targeted sites more efficiently than 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE)-PEGylated lipoplexes.

Application

C8 PEG2000 Ceramide, or N-octanoyl-sphingosine-1-{succinyl[methoxy(polyethylene glycol)2000]} is suitable for PEGylated lipoplexes preparation.

Packaging

5 mL Amber Glass Screw Cap Vial (880170P-25mg)

Legal Information

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Storage Class Code

11 - Combustible Solids

WGK

WGK 3


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Anna Lechanteur et al.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 93, 493-503 (2016-09-07)
The delivery of small interfering RNA (siRNA) is an attractive therapeutic approach to treat several pathologies, such as viral infections or cancers. However, the stability and the efficacy of these biotherapies are still a major obstacle to their use. Cationic

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service